Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer

• E. Martin Perez ^[1] ; J. E. Domínguez Muñoz ^[3] ; F. Botella Romero ^[4] ; L. Cerezo ^[1] ; F. Matute Teresa ^[2] ; T. Serrano ^[5] ; R. Vera ^[6]
  1. [1] Hospital Universitario de la Princesa

     Hospital Universitario de la Princesa

     Madrid, España

     
  2. [2] Hospital Clínico San Carlos de Madrid

     Hospital Clínico San Carlos de Madrid

     Madrid, España

     
  3. [3] Department of Gastroenterology and Hepatology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
  4. [4] Department of Endocrinology, Hospital General Universitario, Albacete, Spain
  5. [5] Department of Pathology, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
  6. [6] Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 22, Nº. 11, 2020, págs. 1963-1975
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Pancreatic cancer (PC) remains one of the most aggressive tumors with an increasing incidence rate and reduced survival. Although surgical resection is the only potentially curative treatment for PC, only 15–20% of patients are resectable at diag-nosis. To select the most appropriate treatment and thus improve outcomes, the diagnostic and therapeutic strategy for each patient with PC should be discussed within a multidisciplinary expert team. Clinical decision-making should be evidence-based, considering the staging of the tumor, the performance status and preferences of the patient. The aim of this guideline is to provide practical and evidence-based recommendations for the management of PC